Image 1
Hydrochlorothiazide Tablet
Product Images NDC 0172-2089
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Hydrochlorothiazide (NDC 0172-2089). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image 2
This is a description of Hydrochlorothiazide, an RX only drug which comes in tablet form. It contains 25 mg of hydrochlorothiazide, USP. The package insert contains information about the drug's dosing information. It is to be stored at a temperature of 20 to 25 degrees Celsius. The tablet container requires child-resistant closure. Teva Czech Industries manufactures it in the Czech Republic for Teva Pharmaceuticals, based in New Jersey. The text also includes a serialization coding area which contains a serialized number.*
Image 3
This is a description for Hydrochlorothiazide Tablets, USP. Each tablet contains 50mg of hydrochlorothiazide. The usual dosage information can be found in the package insert. The tablets should be stored at 20°C to 25°C (68°F to 77°F). They should be dispensed in a well-closed container and kept out of the reach of children. The manufacturer is Teva Czech, located in Opava-Komarov, Czech Republic. The medication is manufactured for Teva Pharmaceuticals in Parsippany, NJ, and has a National Drug Code of 0172-2089-60 and a Global Trade Item Number of 00301722089602. The description also includes a Revision Date of 3/2022 and a serialization coding area.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
